Yong Zhang

Yong Zhang


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2022 in International Journal of Biological Sciences
Verified
Journal Article
Open access
YTYongchang Tang
Yongchang Tang
LXLei Xu
Lei Xu
YRYupeng Ren
Yupeng Ren
YLYuxuan Li
Yuxuan Li
FYFeng Yuan
Feng Yuan
ZYZhicheng Yao
Zhicheng Yao
MVI has significant clinical value for treatment selection and prognosis evaluation in hepatocellular carcinoma (HCC). We aimed to construct a model based on MVI-Related Genes (MVIRGs) for risk assessment and prognosis prediction in patients with HCC. This study utilized various statistical analysis methods for prognostic model construction and validation in the Cancer Genome Atlas (TCGA) and International Cancer Genome Consortium (ICGC) cohorts, respectively. In addition, immunohistochemistry and qRT-PCR were used to analyze and identify the value of the model in our cohort. After the analyses, 153 differentially expressed MVIRGs were identified, and three key genes were selected to construct a prognostic model. The high-risk group showed significantly lower overall survival (OS), and this trend was observed in all subgroups: different age groups, genders, stages, and grades. Risk score was a risk factor independent of age, gender, stage, and grade. Moreover, the ICGC cohort validated the prognostic value of the model corresponding to the TCGA. In our cohort, qRT-PCR and immunohistochemistry showed that all three genes had higher expression levels in HCC samples than in normal controls. High expression levels of genes and high-risk scores showed significantly lower recurrence-free survival (RFS) and OS, especially in MVI-positive HCC samples. Therefore, the prognostic model constructed by three MVIRGs can reliably predict the RFS and OS of patients with HCC and is valuable for guiding clinical treatment selection and prognostic assessment of HCC.

30 November 2021 in European Journal of Nuclear Medicine and Molecular Imaging
Verified
Journal Article
Closed access
PDF file
ZYZhilong Yi
Zhilong Yi
SHSiqi Hu
Siqi Hu
XLXiaofeng Lin
Xiaofeng Lin
QZQiong Zou
Qiong Zou
MZMinHong Zou
MinHong Zou
YZYong Zhang
Yong Zhang

15 October 2020 in BMC Medical Imaging
Verified
Journal Article
Open access
PDF file
SJShu-Qin Jiang
Shu-Qin Jiang
TYTing Yang
Ting Yang
QZQiong Zou
Qiong Zou
LXLei Xu
Lei Xu
TYTing Ye
Ting Ye
YZYong Zhang
Yong Zhang
Background: This study aimed to compare the sensitivity of99mTc-MIBI SPECT/CT,99mTc-MIBI planar scintigraphy and ultrasonography (US) in patients with secondary hyperparathyroidism (SHPT), and to explore the factors that affect the sensitivity of99mTc-MIBI SPECT/CT.Methods: In this retrospective study, forty-six patients with SHPT who underwent99mTc-MIBI planar scintigraphy,99mTc-MIBI SPECT/CT and US were enrolled. They underwent surgery within 1 month. We compared the sensitivity of the different imaging methods based on the lesions according to the pathological results. The parathyroid lesions on99mTc-MIBI SPECT/CT images were divided into missed diagnosis group (MDG) and non-missed diagnosis group (NMDG). We compared the lesion to background ratio (LBR), maximum diameter, volume, the mean CT Hounsfield unit values (CTmean) and location of lesions between MDG and NMDG.Results: The sensitivity of99mTc-MIBI SPECT/CT,99mTc-MIBI planar scintigraphy and US were 70.30% versus 48.48% versus 61.82%, respectively. The sensitivity of99mTc-MIBI SPECT/CT combined US was 79.39%, which was higher than99mTc-MIBI SPECT/CT with significant difference (P = 0.000). On99mTc-MIBI SPECT/CT images, the LBR, maximum diameter and volume of lesions in MDG was smaller than those in NMDG with significant difference (P < 0.001). The average LBR, maximum diameter and volume of lesions in MDG and NMDG were 3.42 ± 1.28, 9.32 ± 2.69 mm, 208.51 ± 163.22 mm3versus 6.75 ± 5.08, 15.03 ± 4.94 mm and 863.85 ± 1216.0 mm3, respectively.Conclusions: 99mTc-MIBI SPECT/CT exhibited the highest sensitivity among the three methods. When99mTc-MIBI SPECT/CT combined with US, the sensitivity can be further improved. Lesions with lower MIBI uptake and smaller lesions on99mTc-MIBI SPECT/CT images were easily missed.

18 September 2020 in Abdominal Radiology
Verified
Journal Article
Closed access
PDF file
QZQiong Zou
Qiong Zou
JJJu Jiao
Ju Jiao
MZMin-Hong Zou
Min-Hong Zou
MLMing-Zhao Li
Ming-Zhao Li
TYTing Yang
Ting Yang
YZYong Zhang
Yong Zhang

1 July 2019 in Nuclear Medicine Communications
Verified
Journal Article
Closed access
TYTing Yang
Ting Yang
SZShi-Yang Zheng
Shi-Yang Zheng
JJJu Jiao
Ju Jiao
QZQiong Zou
Qiong Zou
YZYong Zhang
Yong Zhang
The incidence of papillary thyroid microcarcinoma (PTMC) has been increasing sharply, the current statement about whether PTMC patients should undergo radioactive iodine (RAI) remnant ablation is still controversial, mainly because it is uncertain whether RAI treatment can reduce the recurrence rate. To evaluate the effectiveness of RAI remnant ablation for thyroid cancer-related outcomes of PTMC patients. We comprehensively searched PubMed, Cochrane Library, Scopus and Science Direct for studies that compared the effectiveness after total-thyroidectomy or near total-thyroidectomy, with or without RAI remnant ablation treatment. Random and fixed-effects meta-analytical models were used where indicated, and between-study heterogeneity was assessed. Twenty-two studies, which included 8724 patients, met our search criteria and were assessed. For PTMC patients treated by total thyroidectomy or near-total thyroidectomy, the locoregional recurrence rates were 1.92 and 7.36% [risk ratio (RR)=0.45; 95% confidence interval (CI)=0.18–1.11; P=0.08] for patients with or without RAI treatment respectively, the distant metastasis rates were 1.39 and 2.46% (RR=0.64; 95% CI=0.28–1.48; P=0.30), and the thyroid cancer-related mortality rates were 0.98 and 1.76% (RR=0.68; 95% CI=0.22–2.09; P=0.50). For PTMC patients who have already treated by total thyroidectomy or near-total thyroidectomy, incremental RAI remnant ablation may significantly improve thyroid cancer-related outcomes.

27 October 2021 in Nuclear Medicine Communications
Verified
Journal Article
Open access
LXLei Xu
Lei Xu
QZQiong Zou
Qiong Zou
JJJu Jiao
Ju Jiao
YZYong Zhang
Yong Zhang
Purpose: The true impact of postoperative radioiodine therapy on survival has been controversial for patients with poorly differentiated thyroid carcinoma (PDTC). We aimed to determine the impact of postoperative radioiodine on survival in PDTC through a population-based study. Methods: Data on patients with PDTC were collected from the US SEER database (2004 to 2015). Patients were divided into the radioiodine group and nonradioiodine group. Survival comparison between groups was evaluated by Kaplan–Meier curves, log-rank test and multivariate Cox regression analysis. Akaike information criterion was used to select variables in the nomogram. The performance of the nomogram was assessed by discrimination (C-index) and calibration plots. Results: The radioiodine group had more aggressive features, such as advanced tumor node metastasis stage and radical surgery, compared to the nonradioiodine group. PDTC patients receiving radioiodine therapy had a significant survival advantage in terms of overall survival (OS) (P = 0.001) but not in terms of cancer-specific survival (P = 0.083). Multivariate analysis revealed radioiodine therapy was an independent favorable factor for OS in PDTC patients (hazard ratio = 0.57; 95% CI, 0.44–0.75, P < 0.001). Subgroup analysis identified patients’ characteristics favoring radioiodine therapy. The nomogram (age, tumor size, extension, neck lymph nodes metastasis and radioiodine therapy) of OS for predicting 3-, 5- and 10-year OS probability showed good discrimination (C-index, 0.797) and calibration power. Conclusion: Postoperative radioiodine therapy can prolong the long-term OS in patients with PDTC, and is an independent favorable prognostic factor for those patients. Further prospective studies are warranted.